<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04878042</url>
  </required_header>
  <id_info>
    <org_study_id>20121617</org_study_id>
    <nct_id>NCT04878042</nct_id>
  </id_info>
  <brief_title>COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray</brief_title>
  <official_title>The Negativisation Rate of Positive PCR Swab Tests for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Treatment With Hydrogen Peroxide: a Double-blind Placebo-controlled Randomised Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EPISTATA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EPISTATA</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hydrogen peroxide is produced physiologically by oral bacteria and plays a significant role&#xD;
      in the balance of oral microecology since it is an important antimicrobial agent. In the&#xD;
      epithelial cells, the enzyme superoxide dismutase catalyzes a reaction leading from hydrogen&#xD;
      peroxide to the ion superoxide. The induced oxidative stress stimulates a local innate&#xD;
      response via activation of the toll-like receptors and the NF-ÎºB. Those kinds of reactions&#xD;
      are also activated by viral infections. Virus-induced oxidative stress plays an important&#xD;
      role in the regulation of the host immune system and the specific oxidant-sensitive pathway&#xD;
      is one of the effective strategies against viral infections. Therefore, nose/mouth/throat&#xD;
      washing with hydrogen peroxide may enhance those local innate responses to viral infections.&#xD;
      The investigators hypothesised that a treatment with a mouth wash and a nasal spray&#xD;
      containing a diluted solution of hydrogen peroxide may accelerate the negativisation rate of&#xD;
      a positive PCR swab test for SARS-CoV-2 (COVID-19).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2021</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The negativisation rate of a positive SARS-CoV-2 (COVID-19) PCR nose swab test</measure>
    <time_frame>4 days</time_frame>
    <description>A repeated SARS-CoV-2 PCR nose swab test after a previous positive SARS-CoV-2 PCR nose swab test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mouth wash and nasal spray containing a diluted solution of hydrogen peroxide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mouth wash and nasal spray not containing a diluted solution of hydrogen peroxide</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hydrogen peroxide</intervention_name>
    <description>Mouth wash and nasal spray 3 times a day for 3 days</description>
    <arm_group_label>Active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Mouth wash and nasal spray 3 times a day for 3 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - recent positive SARS-CoV-2 PCER swab test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - severe Covid19 disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio I Lazzarino, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EPISTATA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio I Lazzarino, MD PhD</last_name>
    <phone>+447835692213</phone>
    <email>director@epistata.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>AIAS di Afragola</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arturo Armone Caruso, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Nuova ITOR</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diego Caputo, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 4, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>EPISTATA</investigator_affiliation>
    <investigator_full_name>Antonio Lazzarino</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrogen Peroxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

